Ischemia Detection During Development of Acute Compartment Syndrome

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorOslo University Hospital

About this trial

This is an open, observational, prospective, descriptive, single-centre study including 60 patients. The study is designed to investigate if IscAlert sensor system can be used for reliable and continuous tissue carbon dioxide (pCO2)- and temperature monitoring in muscular tissue in lower extremity in patients at risk of developing acute compartment syndrome.

Eligibility criteria

Qualifiers

Must have a leg fracture that, perceived by the clinician, could give rise to later developing acute compartment syndrome condition.

Subject must be 18 years or more.

Able to sign informed consent.

Expected cooperation of the patients for the treatment and follow up

Disqualifiers

Another study interfering with current study

Any reason why, in the opinion of the investigator, the patient should not participate.

Patients where a fasciotomy has already been decided should be performed

Trial design

Treatments tested in this trial

  • IscAlert sensor(s) in patient with risk of acute compartment syndrome

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Oslo University Hospital

Lead sponsor

Sensocure AS

Collaborator